Clinical trial
Efficacy of Diamel in the Treatment of Polycystic Ovary Syndrome
NCT01051024 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Diamel in the Treatment of Polycystic Ovary Syndrome
- Lead sponsor
- Catalysis SL
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- April 30, 2011
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.